Jesper Stentoft - Concepedia

Author

Jesper Stentoft

Also Known As

Christina Ellervik, J Stentoft, J. Stentoft, JESPER STENTOFT, Jesper Stentoft, P. Johansen, Stentoft, J, Stentoft, Jesper

106

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Aarhus University Hospital Karolinska University Hospital Helsinki University Hospital Uppsala University Hospital St Olav's University Hospital

About

Jesper Stentoft is an author at Aarhus University Hospital specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	362
2	Immunology	7	7	273
3	Health Sciences	4	4	163
4	Cell Biology	2	2	40
5	Allergy	1	1	24

Jesper Stentoft

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study Andreas Hochhaus, Tamás Masszi, Francis J. Giles, Leukemia	2017	286
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia Bengt Simonsson, Tobias Gedde‐Dahl, Berit Markevärn, Blood	2011	194
Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML Rebecca Warfvinge, Linda Geironson, Mikael N.E. Sommarin, Blood	2017	175
Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study David M. Ross, Tamás Masszi, María Teresa Gómez‐Casares, Journal of Cancer Research and Clinical Oncology	2018	140
Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial Jerald P. Radich, Andreas Hochhaus, Tamás Masszi, Leukemia	2021	77
Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients Henrik Hjorth‐Hansen, Jesper Stentoft, Johan Richter, Leukemia Hematological MalignancyOncologyImmunologyClinical TrialsHematology	2016	69
Kinetics of BCR‐ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real‐time polymerase chain reaction Jesper Stentoft, Niels Pallisgaard, Eigil Kjeldsen, European Journal Of Haematology	2001	62
Minimal residual core binding factor AMLs by real time quantitative PCR—Initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse Jesper Stentoft, Peter Hokland, Mette Østergaard, Leukemia Research Hematological MalignancyPrognostic BiomarkersMedicineClose MonitoringImmunology	2005	59
Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses Trine Alma Knudsen, Vibe Skov, Kristen E. Stevenson, Blood Advances Interferon-α Vs HydroxyureaGeneticsMixed-phenotype Acute LeukemiaImmunologyMolecular Biology	2021	58
Cerebral oedema as a possible complication of treatment with imatinib Monika Ebnoether, Jesper Stentoft, J. Ford, The Lancet Cerebral OedemaNeuro-oncologyPathologyBrain InjuryNeurology	2002	49

Page 1